| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AADvac1, an Active Immunotherapy for Alzheimer’s Disease and Non Alzheimer Tauopathies: An Overview of Preclinical and Clinical Development
|
Novak, P.
|
|
2018
|
|
1 |
p. 63-69
|
article
|
| 2 |
Accelerating Innovations for Enhanced Brain Health. Can Artificial Intelligence Advance New Pathways for Drug Discovery for Alzheimer’s and other Neurodegenerative Disorders?
|
Khachaturian, A. S.
|
|
|
|
1 |
p. 1-4
|
article
|
| 3 |
ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aβ Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan
|
Siemers, Eric
|
|
|
|
1 |
p. 19-24
|
article
|
| 4 |
Age- and Sex-Different Associations between Cognitive Performance and Inflammatory Biomarkers in Community Dwelling Older Adults: towards Precision Preventive Strategies
|
Chen, B.-A.
|
|
|
|
1 |
p. 104-111
|
article
|
| 5 |
Alzheimer’s Disease and Aging Association: Identification and Validation of Related Genes
|
Liu, T.
|
|
|
|
1 |
p. 196-213
|
article
|
| 6 |
AMBAR: A Therapeutical Approach for Alzheimer’s Disease Patients Regardless of Amyloid Status
|
Costa, Montserrat
|
|
|
|
1 |
p. 148-149
|
article
|
| 7 |
Are Population-Level Approaches to Dementia Risk Reduction Under-Researched? A Rapid Review of the Dementia Prevention Literature
|
Walsh, Sebastian
|
|
|
|
1 |
p. 241-248
|
article
|
| 8 |
Assessing the Impact of Factors that Influence the Ketogenic Response to Varying Doses of Medium Chain Triglyceride (MCT) Oil
|
Juby, Angela G.
|
|
|
|
1 |
p. 19-28
|
article
|
| 9 |
Association between 9p21–23 Locus and Frailty in a Community-Dwelling Greek Population: Results from the Hellenic Longitudinal Investigation of Ageing and Diet
|
Mourtzi, N.
|
|
|
|
1 |
p. 77-85
|
article
|
| 10 |
Association of Balance Impairment with Risk of Incident Dementia among Older Adults
|
Kim, H. J.
|
|
|
|
1 |
p. 130-137
|
article
|
| 11 |
Association of Blood MicroRNA Expression and Polymorphisms with Cognitive and Biomarker Changes in Older Adults
|
Sadlon, A.
|
|
|
|
1 |
p. 230-240
|
article
|
| 12 |
Association of Multi-Domain Factors with Cognition in the UK Biobank Study
|
Tan, W. Y.
|
|
|
|
1 |
p. 13-21
|
article
|
| 13 |
Association of Vitamin D Levels with Incident All-Cause Dementia in Longitudinal Observational Studies: A Systematic Review and Meta-analysis
|
Kalra, Anjani
|
|
|
|
1 |
p. 14-20
|
article
|
| 14 |
Associations of Cardiovascular and Non-Cardiovascular Comorbidities with Dementia Risk in Patients with Diabetes: Results from a Large UK Cohort Study
|
Zheng, B.
|
|
|
|
1 |
p. 86-91
|
article
|
| 15 |
Associations of Later-Life Education, the BDNF Val66Met Polymorphism and Cognitive Change in Older Adults
|
Ward, David D.
|
|
|
|
1 |
p. 37-42
|
article
|
| 16 |
Associations of Long-Term Tea Consumption with Depressive and Anxiety Symptoms in Community-Living Elderly: Findings from the Diet and Healthy Aging Study
|
Chan, S.-P.
|
|
2017
|
|
1 |
p. 21-25
|
article
|
| 17 |
Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer’s Disease
|
Petersen, Kellen K.
|
|
|
|
1 |
p. 112-119
|
article
|
| 18 |
A Systematic Review on the Feasibility of Salivary Biomarkers for Alzheimer’s Disease
|
Bouftas, M.
|
|
|
|
1 |
p. 84-91
|
article
|
| 19 |
At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related Research
|
Ford, J.
|
|
|
|
1 |
p. 67-76
|
article
|
| 20 |
Bifidobacterium Breve A1 Supplementation Improved Cognitive Decline in Older Adults with Mild Cognitive Impairment: An Open-Label, Single-Arm Study
|
Kobayashi, Yodai
|
|
2018
|
|
1 |
p. 70-75
|
article
|
| 21 |
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
|
Udeh-Momoh, C.
|
|
|
|
1 |
p. 12-21
|
article
|
| 22 |
Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer’s and Parkinson’s Patients
|
Fang, Cheng
|
|
|
|
1 |
p. 25-33
|
article
|
| 23 |
Burden of Illness in People with Alzheimer’s Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality
|
Lanctôt, Krista L.
|
|
|
|
1 |
p. 97-107
|
article
|
| 24 |
Care Management to Promote Treatment Adherence in Patients with Cognitive Impairment and Vascular Risk Factors: A Demonstration Project
|
Bonner, Laura M.
|
|
2017
|
|
1 |
p. 36-41
|
article
|
| 25 |
Change on Clinical Trial Outcome Assessments: The Search for Meaningfulness
|
Cummings, Jeffrey
|
|
|
|
1 |
p. 5-6
|
article
|
| 26 |
China Alzheimer’s Disease and Neurodegenerative Disorder Research (CANDOR) -A Prospective Cohort Study for Alzheimer’s Disease and Vascular Cognitive Impairment
|
Li, S.
|
|
|
|
1 |
p. 214-221
|
article
|
| 27 |
Clusters of Dementia Literacy: Implications from a Survey of Older Adults
|
Barak, Yoram
|
|
|
|
1 |
p. 172-177
|
article
|
| 28 |
Cognitive Frailty and Incidence of Dementia in Older Persons
|
Shimada, Hiroyuki
|
|
2017
|
|
1 |
p. 42-48
|
article
|
| 29 |
Cognitive Performance and Incident Alzheimer’s Dementia in Men Versus Women
|
Liampas, Ioannis
|
|
|
|
1 |
p. 162-170
|
article
|
| 30 |
Combining Geospatial Analysis with Dementia Risk Utilising General Practice Data: A Systematic Review
|
Bagheri, Nasser
|
|
2017
|
|
1 |
p. 71-77
|
article
|
| 31 |
Communicating Personal Risk Profiles of Alzheimer’s Disease to Older Adults: A Pilot Trial
|
Choi, Isabella
|
|
|
|
1 |
p. 144-150
|
article
|
| 32 |
Comparative Analysis of Different Definitions of Amyloid-β Positivity to Detect Early Downstream Pathophysiological Alterations in Preclinical Alzheimer
|
Milà-Alomà, M.
|
|
|
|
1 |
p. 68-77
|
article
|
| 33 |
Comparative Effectiveness of Behavioral Interventions to Prevent or Delay Dementia: One-Year Partner Outcomes
|
Amofa, P. A.
|
|
|
|
1 |
p. 33-40
|
article
|
| 34 |
Computerized Cognitive Training in Mild Cognitive Impairment: Findings in African Americans and Caucasians
|
Nwosu, Adaora
|
|
|
|
1 |
p. 149-154
|
article
|
| 35 |
Consistency between Treatment Effects on Clinical and Brain Atrophy Outcomes in Alzheimer’s Disease Trials
|
ten Kate, M.
|
|
|
|
1 |
p. 38-47
|
article
|
| 36 |
Costs and Resource Use Associated with Alzheimer’s Disease in Italy: Results from an Observational Study
|
Bruno, G.
|
|
2017
|
|
1 |
p. 55-64
|
article
|
| 37 |
Data-Driven Thresholding Statistically Biases ATN Profiling across Cohort Datasets
|
Salimi, Y.
|
|
|
|
1 |
p. 185-195
|
article
|
| 38 |
Delayed-Start Analyses in the Phase 3 Solanezumab EXPEDITION3 Study in Mild Alzheimer’s Disease
|
Liu-Seifert, Hong
|
|
2018
|
|
1 |
p. 8-14
|
article
|
| 39 |
Dementia: Creating a Knowledge-Based Healthcare Profession
|
Scerri, Charles
|
|
2017
|
|
1 |
p. 85-86
|
article
|
| 40 |
Dementia Prevention: A Global Challenge in Urgent Need of Solutions
|
Price, G.
|
|
|
|
1 |
p. 1-2
|
article
|
| 41 |
Demographic Analysis of Industry-Sponsored Alzheimer’s Disease Trial Populations in the United States
|
Peroutka, Stephen J.
|
|
|
|
1 |
p. 130-132
|
article
|
| 42 |
Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer’s Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?
|
Messner, Donna A.
|
|
2018
|
|
1 |
p. 20-26
|
article
|
| 43 |
Detecting Treatment Group Differences in Alzheimer’s Disease Clinical Trials: A Comparison of Alzheimer’s Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB)
|
Wessels, Alette M.
|
|
2018
|
|
1 |
p. 15-20
|
article
|
| 44 |
Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population
|
Liu, Ying
|
|
|
|
1 |
p. 7-12
|
article
|
| 45 |
Developing a Skilled Workforce: Impact of a Postgraduate Programme on Dementia Knowledge, Attitudes and Training Needs
|
Scerri, Charles
|
|
|
|
1 |
p. 117-118
|
article
|
| 46 |
Diet as a Risk Factor for Cognitive Decline in African Americans and Caucasians with a Parental History of Alzheimer’s Disease: A Cross-Sectional Pilot Study Dietary Patterns
|
Nutaitis, A. C.
|
|
2018
|
|
1 |
p. 50-55
|
article
|
| 47 |
Digital Clock Drawing as an Alzheimer’s Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults
|
Thompson, Louisa I.
|
|
|
|
1 |
p. 79-87
|
article
|
| 48 |
Diversifying Recruitment Registries: Considering Neighborhood Health Metrics
|
Grill, Joshua D.
|
|
|
|
1 |
p. 119-125
|
article
|
| 49 |
Effects of Mindfulness-Based Tai Chi Chuan on Physical Performance and Cognitive Function among Cognitive Frailty Older Adults: A Six-Month Follow-Up of a Randomized Controlled Trial
|
Jiayuan, Z.
|
|
|
|
1 |
p. 104-112
|
article
|
| 50 |
Effects of Omega-3 Fatty Acids on Resting Cerebral Perfusion in Patients with Mild Cognitive Impairment: A Randomized Controlled Trial
|
Schwarz, Claudia
|
|
2017
|
|
1 |
p. 26-30
|
article
|
| 51 |
Embryo Selection for a Carrier of an Early-Onset Alzheimer’s Disease-Associated Mutation in the PSEN1 Gene
|
Valdés-Martínez, O. H.
|
|
|
|
1 |
p. 144-147
|
article
|
| 52 |
Erratum to: Alzheimer’s Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer’s Disease
|
Hendrix, Suzanne B.
|
|
|
|
1 |
p. 151
|
article
|
| 53 |
Erratum to: Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats
|
Souchet, B.
|
|
|
|
1 |
p. 150
|
article
|
| 54 |
Erratum to: Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer’s Disease Suggest Disease Modification Potential
|
Abushakra, Susan
|
|
|
|
1 |
p. 264
|
article
|
| 55 |
Erratum to: Digital Clock Drawing as an Alzheimer’s Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults
|
Thompson, Louisa I.
|
|
|
|
1 |
p. 263
|
article
|
| 56 |
Establishing Clinically Meaningful Change on Outcome Assessments Frequently Used in Trials of Mild Cognitive Impairment Due to Alzheimer’s Disease
|
Lansdall, Claire J.
|
|
|
|
1 |
p. 9-18
|
article
|
| 57 |
Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers
|
Mattke, Soeren
|
|
|
|
1 |
p. 155-161
|
article
|
| 58 |
Evidence-Based Tools for Dietary Assessments in Nutrition Epidemiology Studies for Dementia Prevention
|
Abbott, K. A.
|
|
|
|
1 |
p. 49-53
|
article
|
| 59 |
Expectancy Does Not Predict 18-month Treatment Outcomes with Cognitive Training in Mild Cognitive Impairment
|
Motter, Jeffrey N.
|
|
|
|
1 |
p. 71-78
|
article
|
| 60 |
First Experiences with Amyloid-Related Imaging Abnormalities — Yet without Imaging that Can Rule Out Cerebral Injury or Monitor Efficacy of Recommended Management
|
Høilund-Carlsen, Poul F.
|
|
|
|
1 |
p. 259-260
|
article
|
| 61 |
Gender-Specific Design and Effectiveness of Non-Pharmacological Interventions against Cognitive Decline — Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Zülke, Andrea E.
|
|
|
|
1 |
p. 69-82
|
article
|
| 62 |
Geniposidic Acid Confers Neuroprotective Effects in a Mouse Model of Alzheimer’s Disease through Activation of a PI3K/AKT/GAP43 Regulatory Axis
|
Chen, Q. Y.
|
|
|
|
1 |
p. 158-171
|
article
|
| 63 |
Geroscience and the Role of Aging in the Etiology and Management of Alzheimer’s Disease
|
Sierra, F.
|
|
|
|
1 |
p. 2-3
|
article
|
| 64 |
Global Energy Metabolism Deficit in Alzheimer Disease Brain
|
Patel, Viharkumar
|
|
|
|
1 |
p. 171-178
|
article
|
| 65 |
Health Literacy in Individuals at Risk for Alzheimer’s Dementia: A Systematic Review
|
Rostamzadeh, Ayda
|
|
|
|
1 |
p. 47-55
|
article
|
| 66 |
High-Fat Diet-Induced Diabetic Conditions Exacerbate Cognitive Impairment in a Mouse Model of Alzheimer’s Disease Via a Specific Tau Phosphorylation Pattern
|
Ito, Y.
|
|
|
|
1 |
p. 138-148
|
article
|
| 67 |
How Larger Society Can Give a Helping Hand to Worldwide FINGERS
|
Daly, Timothy
|
|
|
|
1 |
p. 185
|
article
|
| 68 |
How Modifiable Are Modifiable Dementia Risk Factors? A Framework for Considering the Modifiability of Dementia Risk Factors
|
Bransby, Lisa
|
|
|
|
1 |
p. 22-37
|
article
|
| 69 |
Increased Functional Connectivity After Listening to Favored Music in Adults With Alzheimer Dementia
|
King, J. B.
|
|
2018
|
|
1 |
p. 56-62
|
article
|
| 70 |
Integrating Biomarker Outcomes into Clinical Trials for Alzheimer’s Disease in Down Syndrome
|
Rafii, Michael S.
|
|
|
|
1 |
p. 48-51
|
article
|
| 71 |
Investigating the Factor Structure of the Preclinical Alzheimer Cognitive Composite and Cognitive Function Index across Racial/Ethnic, Sex, and Aβ Status Groups in the A4 Study
|
Ruthirakuhan, M.
|
|
|
|
1 |
p. 48-55
|
article
|
| 72 |
Is “Pre-Preclinical AD” Helpful to the EU/US CTAD Task Force?
|
Daly, Timothy
|
|
|
|
1 |
p. 184
|
article
|
| 73 |
Is Reluctance to Share Alzheimer’s Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment?
|
Cox, Chelsea G.
|
|
|
|
1 |
p. 52-58
|
article
|
| 74 |
Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults ≥ 55 Years Old. A Study Protocol for a Double-Blinded Randomized Controlled Clinical Trial
|
Avgerinos, K. I.
|
|
|
|
1 |
p. 54-66
|
article
|
| 75 |
Lifestyle and Socioeconomic Transition and Health Consequences of Alzheimer’s Disease and Other Dementias in Global, from 1990 to 2019
|
Cui, Y.
|
|
|
|
1 |
p. 88-96
|
article
|
| 76 |
Living Environment, Built Environment and Cognitive Function among Older Chinese Adults: Results from a Cross-Sectional Study
|
Fangfang, H.
|
|
|
|
1 |
p. 126-135
|
article
|
| 77 |
Long Chain Omega-3 Fatty Acid Intervention in Ageing Adults at Risk of Dementia Following Repeated Head Trauma. Low-Level Support or an Opportunity for an Unanswered Question?
|
Patch, C. S.
|
|
|
|
1 |
p. 29-32
|
article
|
| 78 |
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
|
Lim, Yen Ying
|
|
|
|
1 |
p. 178-183
|
article
|
| 79 |
Longitudinal Comparison of in Clinic and at Home Administration of the Cogstate Brief Battery and Demonstrated Practice Effects in the Mayo Clinic Study of Aging
|
Stricker, Nikki H.
|
|
|
|
1 |
p. 21-28
|
article
|
| 80 |
Long-Term Tea Consumption and Depressive and Anxiety Symptoms in Elderly
|
Joob, Beuy
|
|
2018
|
|
1 |
p. 87
|
article
|
| 81 |
Low Amino Acid Score of Breakfast is Associated with the Incidence of Cognitive Impairment in Older Japanese Adults: A Community-Based Longitudinal Study
|
Kinoshita, K.
|
|
|
|
1 |
p. 151-157
|
article
|
| 82 |
Mechanisms Underlying Non-Pharmacological Dementia Prevention Strategies: A Translational Perspective
|
Alanko, V.
|
|
|
|
1 |
p. 3-11
|
article
|
| 83 |
Modifiable Risk Factors for Accelerated Decline in Processing Speed: Results from Three Dutch Population Cohorts
|
Jaarsma, E.
|
|
|
|
1 |
p. 108-116
|
article
|
| 84 |
Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer’s Disease, and Dementia: From FINGER to World-Wide FINGERS
|
Rosenberg, A.
|
|
|
|
1 |
p. 29-36
|
article
|
| 85 |
Multimodal Preventive Trial for Alzheimer’s Disease: MIND-ADmini Pilot Trial Study Design and Progress
|
Sindi, S.
|
|
|
|
1 |
p. 30-39
|
article
|
| 86 |
Neuroprotective Effects of Guarana (Paullinia cupana Mart.) against Vincristine in Vitro Exposure
|
Veloso, C. F.
|
|
2017
|
|
1 |
p. 65-70
|
article
|
| 87 |
Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force
|
Soto, Maria
|
|
|
|
1 |
p. 56-64
|
article
|
| 88 |
Nutrition to Prevent or Treat Cognitive Impairment in Older Adults: A GRADE Recommendation
|
Buckinx, F.
|
|
|
|
1 |
p. 110-116
|
article
|
| 89 |
Oral Health as a Risk Factor for Alzheimer Disease
|
Pruntel, S. M.
|
|
|
|
1 |
p. 249-258
|
article
|
| 90 |
Oversimplification of Dementia Risk Reduction Messaging Is a Threat to Knowledge Translation in Dementia Prevention Research
|
Anstey, Kaarin J.
|
|
2017
|
|
1 |
p. 2-4
|
article
|
| 91 |
Pharmacological Inventions for Alzheimer Treatment in the United States of America: A Revision Patent from 2010–2020
|
Navarro-Gómez, N.
|
|
|
|
1 |
p. 50-68
|
article
|
| 92 |
Phase 1/2a Intravenous and Subcutaneous Oligomer-Specific Antibody KHK6640 in Mild to Moderate Alzheimer’s Disease
|
Cantillon, Marc
|
|
|
|
1 |
p. 65-70
|
article
|
| 93 |
Physical Fitness and Apolipoprotein E Genotype Influence Cortical Networking and Intelligence in Adolescents
|
Park, J.
|
|
|
|
1 |
p. 92-99
|
article
|
| 94 |
Pimavanserin in Alzheimer’s Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms
|
Ballard, Clive
|
|
2018
|
|
1 |
p. 27-33
|
article
|
| 95 |
Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer’s Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study
|
Pérez-Grijalba, V.
|
|
2018
|
|
1 |
p. 34-41
|
article
|
| 96 |
Polygenic Risk Score Analysis of Alzheimer’s Disease in Cases without APOE4 or APOE2 Alleles
|
Escott-Price, V.
|
|
2018
|
|
1 |
p. 16-19
|
article
|
| 97 |
Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer’s Disease
|
Daunt, P.
|
|
|
|
1 |
p. 78-83
|
article
|
| 98 |
Prevention of Alzheimer’s Disease and Cognitive Decline with Diet & Lifestyle: Proceedings of the A. G. Leventis Foundation Conference
|
Hershey, M. S.
|
|
|
|
1 |
p. 137-143
|
article
|
| 99 |
Primary Prevention of Dementia: The Future of Population-Based Multidomain Lifestyle Interventions
|
Lee, Yunhwan
|
|
2017
|
|
1 |
p. 5-7
|
article
|
| 100 |
Programmed Death of Microglia in Alzheimer’s Disease: Autophagy, Ferroptosis, and Pyroptosis
|
Qiu, Z.
|
|
|
|
1 |
p. 95-103
|
article
|
| 101 |
Projected Savings to Canadian Provincial Budgets from Reduced Long-Term Care Home Utilization Due to a Disease-Modifying Alzheimer’s Treatment
|
Jun, H.
|
|
|
|
1 |
p. 179-184
|
article
|
| 102 |
Prospective Associations between Plasma Amyloid-Beta 42/40 and Frailty in Community-Dwelling Older Adults
|
Lu, Wan-Hsuan
|
|
|
|
1 |
p. 41-47
|
article
|
| 103 |
Relationships of Hypnotics with Incident Dementia and Alzheimer’s Disease: A Longitudinal Study and Meta-Analysis
|
Hou, J.-H.
|
|
|
|
1 |
p. 117-129
|
article
|
| 104 |
Representation of Racial and Ethnic Minority Populations in Dementia Prevention Trials: A Systematic Review
|
Shaw, A. R.
|
|
|
|
1 |
p. 113-118
|
article
|
| 105 |
Responses
|
Feng, L.
|
|
2018
|
|
1 |
p. 87
|
article
|
| 106 |
Response to Concerns Raised on MRI Surveillance and Clinical Implications of ARIA in Disease Modifying Treatment
|
Howe, Matthew D.
|
|
|
|
1 |
p. 261-262
|
article
|
| 107 |
Revisiting the Cholinergic Hypothesis in Alzheimer’s Disease: Emerging Evidence from Translational and Clinical Research
|
Hampel, Harald
|
|
2018
|
|
1 |
p. 2-15
|
article
|
| 108 |
Revisiting the Hallmarks of Aging to Identify Markers of Biological Age
|
Guerville, Florent
|
|
|
|
1 |
p. 56-64
|
article
|
| 109 |
Risk Estimates of Dementia and Alzheimer’s Disease among Different Whole Grain Food Consumption Categories: A Pilot Study
|
Wang, Kanran
|
|
|
|
1 |
p. 133-136
|
article
|
| 110 |
Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer’s Disease Dementia: Results From a Phase 2 Randomized Clinical Trial
|
Moline, Margaret
|
|
|
|
1 |
p. 7-18
|
article
|
| 111 |
Searching for the Holy Grail Will Need Biomarkers
|
Ramirez, Alfredo
|
|
|
|
1 |
p. 4-6
|
article
|
| 112 |
Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease (SToMP-AD): A Pilot Clinical Trial
|
Gonzales, Mitzi M.
|
|
|
|
1 |
p. 22-29
|
article
|
| 113 |
Socioeconomic Status and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 39 Prospective Studies
|
Wang, A.-Y.
|
|
|
|
1 |
p. 83-94
|
article
|
| 114 |
Systematic and Comparative Analysis of the Burden of Alzheimer’s Disease and Other Dementias in Mexico. Results at the National and Subnational Levels, 1990–2019
|
Agudelo-Botero, M.
|
|
|
|
1 |
p. 120-129
|
article
|
| 115 |
Tau Pathologies Mediate the Associations of Vascular Risk Burden with Cognitive Impairments in Non-demented Elders: The CABLE Study
|
Yu, G.-X.
|
|
|
|
1 |
p. 136-143
|
article
|
| 116 |
The Computerized Cognitive Composite (C3) in A4, an Alzheimer’s Disease Secondary Prevention Trial
|
Papp, Kathryn V.
|
|
|
|
1 |
p. 59-67
|
article
|
| 117 |
The Effect of Baseline Performance and Age on Cognitive Training Improvements in Older Adults: A Qualitative Review
|
Shaw, J. S.
|
|
|
|
1 |
p. 100-109
|
article
|
| 118 |
The Effect of Multidomain Interventions on Global Cognition, Symptoms of Depression and Apathy — A Pooled Analysis of Two Randomized Controlled Trials
|
den Brok, Melina G. H. E.
|
|
|
|
1 |
p. 96-103
|
article
|
| 119 |
The European Prevention of Alzheimer’s Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0
|
Ritchie, Craig William
|
|
|
|
1 |
p. 8-13
|
article
|
| 120 |
The Patient in Your Alzheimer’s Disease Study May be in Another: Duplication and Deception in Clinical Trials of Alzheimer’s Disease
|
Shiovitz, Thomas
|
|
|
|
1 |
p. 43-46
|
article
|
| 121 |
The Relationship of Omega 3 Polyunsaturated Fatty Acids in Red Blood Cell Membranes with Cognitive Function and Brain Structure: A Review Focussed on Alzheimer’s Disease
|
Hooper, Claudie
|
|
2017
|
|
1 |
p. 78-84
|
article
|
| 122 |
The Role of Futility Analyses in Alzheimer’s Disease Clinical Trials
|
Doody, Rachelle
|
|
|
|
1 |
p. 7
|
article
|
| 123 |
The Room Where It Happens: Clinician Reflections on Returning Preclinical Alzheimer’s Biomarker Results to Research Participants
|
Erickson, C. M.
|
|
|
|
1 |
p. 1-6
|
article
|
| 124 |
The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER): Study Design and Protocol
|
Xu, X.
|
|
|
|
1 |
p. 40-48
|
article
|
| 125 |
The Therapeutic Effects of Noninvasive Brain Stimulation Combined with Cognitive Training in Elders with Alzheimer’s Disease or Amnesic Mild Cognitive Impairment
|
Wang, J.-Y.
|
|
|
|
1 |
p. 222-229
|
article
|
| 126 |
The Ups and Downs of Amyloid in Alzheimer’s
|
Siemers, E.
|
|
|
|
1 |
p. 92-95
|
article
|
| 127 |
The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer’s Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
|
Teng, Edmond
|
|
|
|
1 |
p. 41-49
|
article
|
| 128 |
The Value of Pre-Screening in the Alzheimer’s Prevention Initiative (API) Autosomal Dominant Alzheimer’s Disease Trial
|
Rios-Romenets, Silvia
|
|
2017
|
|
1 |
p. 49-54
|
article
|
| 129 |
Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab
|
Klein, Gregory
|
|
|
|
1 |
p. 3-6
|
article
|
| 130 |
Trajectory of the MAPT-PACC-Preclinical Alzheimer Cognitive Composite in the Placebo Group of a Randomized Control Trial: Results from the MAPT Study: Lessons for Further Trials
|
Chhetri, J. K.
|
|
2017
|
|
1 |
p. 31-35
|
article
|
| 131 |
Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years
|
van Eersel, Marlise E. A.
|
|
2018
|
|
1 |
p. 42-49
|
article
|
| 132 |
US Adults’ Likelihood to Participate in Dementia Prevention Drug Trials: Results from the National Poll on Healthy Aging
|
Cox, Chelsea G.
|
|
|
|
1 |
p. 34-40
|
article
|
| 133 |
Usefulness of Anchor Based Methods for Determining Clinically Meaningful Change in MCI due to AD
|
Hendrix, Suzanne B.
|
|
|
|
1 |
p. 7-8
|
article
|
Journal description